ONE of only two current providers in Australia of a groundbreaking Israeli-invented, non-invasive treatment for involuntary shaking has described its non-inclusion in the Medicare Benefits Scheme (MBS) to date as “borderline scandalous”.

Since 2017, Israeli startup Insightec’s Exablate Neuro world-first incisionless treatment to alleviate shaking associated with essential tremor, and also Parkinson’s disease, has been performed successfully on more than 4000 patients around the world.

Read more here.